Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in adolescent alcohol use disorder
NCT03707951Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2019
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in alcohol use disorder (AUD), sponsored by Medical University of South Carolina. Primary endpoint: Alcohol Use During the Final 4 Weeks of Treatment at Week 8. Started Feb 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03707951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707951.